HEADER VIRAL PROTEIN/INHIBITOR 12-MAY-22 7XRY TITLE CRYSTAL STRUCTURE OF MERS MAIN PROTEASE IN COMPLEX WITH INHIBITOR YH- TITLE 2 53 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORF1A; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 1335626; SOURCE 5 GENE: ORF1AB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.LIN,F.L.ZHONG,X.L.ZHOU,J.LI,J.ZHANG REVDAT 2 29-NOV-23 7XRY 1 REMARK REVDAT 1 21-DEC-22 7XRY 0 JRNL AUTH X.HU,C.LIN,Q.XU,X.ZHOU,P.ZENG,P.J.MCCORMICK,H.JIANG,J.LI, JRNL AUTH 2 J.ZHANG JRNL TITL STRUCTURAL BASIS FOR THE INHIBITION OF CORONAVIRAL MAIN JRNL TITL 2 PROTEASES BY A BENZOTHIAZOLE-BASED INHIBITOR. JRNL REF VIRUSES V. 14 2022 JRNL REFN ESSN 1999-4915 JRNL PMID 36146880 JRNL DOI 10.3390/V14092075 REMARK 2 REMARK 2 RESOLUTION. 1.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.86 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.344 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 53545 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 2736 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.8600 - 5.3911 0.99 2704 160 0.2223 0.2300 REMARK 3 2 5.3911 - 4.2802 1.00 2619 141 0.1996 0.2274 REMARK 3 3 4.2802 - 3.7394 1.00 2589 123 0.1986 0.2013 REMARK 3 4 3.7394 - 3.3977 1.00 2576 127 0.2227 0.2320 REMARK 3 5 3.3977 - 3.1542 1.00 2582 114 0.2250 0.2606 REMARK 3 6 3.1542 - 2.9683 1.00 2550 138 0.2333 0.2588 REMARK 3 7 2.9683 - 2.8197 1.00 2538 143 0.2326 0.2888 REMARK 3 8 2.8197 - 2.6969 1.00 2530 132 0.2257 0.2481 REMARK 3 9 2.6969 - 2.5931 1.00 2522 147 0.2300 0.2702 REMARK 3 10 2.5931 - 2.5036 1.00 2507 154 0.2239 0.2592 REMARK 3 11 2.5036 - 2.4254 1.00 2514 133 0.2295 0.2655 REMARK 3 12 2.4254 - 2.3560 1.00 2531 127 0.2314 0.2823 REMARK 3 13 2.3560 - 2.2940 1.00 2533 131 0.2264 0.2605 REMARK 3 14 2.2940 - 2.2381 1.00 2499 139 0.2381 0.2903 REMARK 3 15 2.2381 - 2.1872 1.00 2509 155 0.2341 0.2762 REMARK 3 16 2.1872 - 2.1406 1.00 2523 133 0.2326 0.2756 REMARK 3 17 2.1406 - 2.0978 1.00 2494 141 0.2495 0.2811 REMARK 3 18 2.0978 - 2.0582 1.00 2490 131 0.2568 0.3261 REMARK 3 19 2.0582 - 2.0215 1.00 2512 136 0.2601 0.3990 REMARK 3 20 2.0215 - 1.9900 0.98 2487 131 0.2718 0.3388 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.273 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.121 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.35 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4687 REMARK 3 ANGLE : 0.921 6402 REMARK 3 CHIRALITY : 0.063 736 REMARK 3 PLANARITY : 0.006 810 REMARK 3 DIHEDRAL : 3.747 2674 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7XRY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1300029471. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53633 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 44.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9.700 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.92600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 7VTC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM FORMATE, 0.1M BICINE PH8.5 REMARK 280 20% PEG5000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.00800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.07800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.90000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.07800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.00800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.90000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 5 CG CD CE NZ REMARK 470 ASP A 47 CG OD1 OD2 REMARK 470 ASP A 51 CG OD1 OD2 REMARK 470 GLN A 69 CG CD OE1 NE2 REMARK 470 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 155 CG CD CE NZ REMARK 470 GLU A 156 CG CD OE1 OE2 REMARK 470 VAL A 196 CG1 CG2 REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 GLN A 277 CG CD OE1 NE2 REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 MET A 298 CG SD CE REMARK 470 MET B 25 CG SD CE REMARK 470 ASP B 47 CG OD1 OD2 REMARK 470 ASP B 51 CG OD1 OD2 REMARK 470 ASN B 77 CG OD1 ND2 REMARK 470 ARG B 79 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 156 CG CD OE1 OE2 REMARK 470 GLU B 235 CG CD OE1 OE2 REMARK 470 GLN B 241 CG CD OE1 NE2 REMARK 470 LYS B 257 CG CD CE NZ REMARK 470 GLN B 277 CG CD OE1 NE2 REMARK 470 LYS B 279 CG CD CE NZ REMARK 470 MET B 286 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 148 C19 HUR A 401 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG SER A 232 O GLY B 23 3444 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -125.88 54.12 REMARK 500 ALA B 15 1.56 -69.02 REMARK 500 ASP B 33 -129.21 49.45 REMARK 500 PRO B 75 -166.08 -77.08 REMARK 500 GLU B 156 -79.01 -96.56 REMARK 500 GLN B 167 -34.56 -132.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO B 75 ALA B 76 -147.46 REMARK 500 REMARK 500 REMARK: NULL DBREF 7XRY A 1 301 PDB 7XRY 7XRY 1 301 DBREF 7XRY B 1 301 PDB 7XRY 7XRY 1 301 SEQRES 1 A 301 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 A 301 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 A 301 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 A 301 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 A 301 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 A 301 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 A 301 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 A 301 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 A 301 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 A 301 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 A 301 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 A 301 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 A 301 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 A 301 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 A 301 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 A 301 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 A 301 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 A 301 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 A 301 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 A 301 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 A 301 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 A 301 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 A 301 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 A 301 ILE MET SEQRES 1 B 301 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 B 301 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 B 301 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 B 301 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 B 301 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 B 301 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 B 301 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 B 301 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 B 301 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 B 301 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 B 301 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 B 301 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 B 301 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 B 301 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 B 301 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 B 301 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 B 301 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 B 301 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 B 301 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 B 301 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 B 301 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 B 301 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 B 301 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 B 301 ILE MET HET HUR A 401 41 HET HUR B 401 41 HETNAM HUR N-[(2S)-1-[[(2S)-1-(1,3-BENZOTHIAZOL-2-YL)-1- HETNAM 2 HUR OXIDANYLIDENE-3-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 3 HUR YL]PROPAN-2-YL]AMINO]-4-METHYL-1-OXIDANYLIDENE-PENTAN- HETNAM 4 HUR 2-YL]-4-METHOXY-1H-INDOLE-2-CARBOXAMIDE FORMUL 3 HUR 2(C30 H33 N5 O5 S) FORMUL 5 HOH *203(H2 O) HELIX 1 AA1 SER A 10 ALA A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 PRO A 45 LEU A 49 5 5 HELIX 4 AA4 ASN A 53 SER A 60 1 8 HELIX 5 AA5 THR A 62 HIS A 64 5 3 HELIX 6 AA6 MET A 184 PHE A 188 5 5 HELIX 7 AA7 CYS A 203 ASN A 217 1 15 HELIX 8 AA8 SER A 229 ALA A 239 1 11 HELIX 9 AA9 THR A 248 GLY A 259 1 12 HELIX 10 AB1 ALA A 261 TYR A 273 1 13 HELIX 11 AB2 THR A 292 ILE A 300 1 9 HELIX 12 AB3 SER B 10 ALA B 15 1 6 HELIX 13 AB4 HIS B 41 CYS B 44 5 4 HELIX 14 AB5 PRO B 45 LEU B 49 5 5 HELIX 15 AB6 ASN B 53 MET B 61 1 9 HELIX 16 AB7 THR B 62 HIS B 64 5 3 HELIX 17 AB8 MET B 184 PHE B 188 5 5 HELIX 18 AB9 CYS B 203 ASN B 217 1 15 HELIX 19 AC1 SER B 229 ALA B 239 1 11 HELIX 20 AC2 THR B 248 GLY B 259 1 12 HELIX 21 AC3 ALA B 261 GLY B 275 1 15 HELIX 22 AC4 THR B 292 ILE B 300 1 9 SHEET 1 AA1 7 ALA A 76 LEU A 78 0 SHEET 2 AA1 7 PHE A 66 LYS A 70 -1 N LYS A 70 O ALA A 76 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 MET A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 AA1 7 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 7 AA1 7 VAL A 80 GLN A 86 -1 N ALA A 84 O LYS A 91 SHEET 1 AA2 5 TYR A 104 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 GLU A 169 1 O PHE A 162 N THR A 105 SHEET 3 AA2 5 VAL A 151 GLU A 156 -1 N THR A 154 O ASN A 161 SHEET 4 AA2 5 ALA A 114 TYR A 121 -1 N SER A 116 O TYR A 153 SHEET 5 AA2 5 ARG A 124 VAL A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 TYR A 104 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 GLU A 169 1 O PHE A 162 N THR A 105 SHEET 3 AA3 3 HIS A 175 SER A 178 -1 O THR A 176 N MET A 168 SHEET 1 AA4 6 PHE B 66 GLN B 69 0 SHEET 2 AA4 6 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 3 AA4 6 MET B 25 LEU B 32 -1 O MET B 25 N CYS B 22 SHEET 4 AA4 6 THR B 35 PRO B 39 -1 O TRP B 37 N LEU B 30 SHEET 5 AA4 6 LEU B 89 VAL B 94 -1 O LEU B 92 N VAL B 36 SHEET 6 AA4 6 VAL B 80 GLN B 86 -1 N VAL B 81 O THR B 93 SHEET 1 AA5 5 TYR B 104 PHE B 106 0 SHEET 2 AA5 5 ILE B 160 GLU B 169 1 O PHE B 162 N THR B 105 SHEET 3 AA5 5 VAL B 151 LYS B 155 -1 N THR B 154 O ASN B 161 SHEET 4 AA5 5 ALA B 114 TYR B 121 -1 N SER B 116 O TYR B 153 SHEET 5 AA5 5 ARG B 124 VAL B 132 -1 O PHE B 129 N VAL B 117 SHEET 1 AA6 3 TYR B 104 PHE B 106 0 SHEET 2 AA6 3 ILE B 160 GLU B 169 1 O PHE B 162 N THR B 105 SHEET 3 AA6 3 HIS B 175 SER B 178 -1 O THR B 176 N MET B 168 CRYST1 80.016 93.800 102.156 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012498 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010661 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009789 0.00000